The full name of the CACA Guidelines is China's Guidelines for Integrated Cancer Care.
The Chinese Guidelines for Integrated Cancer Care, or CACA Guidelines for short, is a full-process guideline for the prevention and treatment of malignant tumors in China, initiated by the Chinese Anti-Cancer Association (CACA) with the participation of many academicians and discipline leaders. The guidelines cover 53 common tumor types (Tumor Type Chapter) and 60 diagnostic and therapeutic techniques (Technique Chapter), *** counting 113 guidelines.
The guidelines are cross-cutting in both vertical and horizontal dimensions, focusing on the epidemiological characteristics, genetic background, original research results, and diagnostic, preventive, and control features of the Chinese population, incorporating Chinese research, focusing on Chinese characteristics, taking into account the accessibility of medical care, and reflecting integrated thinking, and are a standardized system of oncology guidelines that is suitable for the Chinese population with both Chinese characteristics and an international perspective.
The 2022 edition of the CACA Guidelines covers 29 malignant tumor fields and 53 types of tumors, with 2,300 pages, and the publication of one bound volume of the Chinese Guidelines for Integrative Diagnosis and Treatment of Tumors and 29 fascicles. 2023 edition of the CACA Guidelines will be divided into six categories, including overall assessment, supportive care, diagnostic techniques, therapeutic techniques, organ preservation, and basic research, and will be composed of 60 technical guidelines.
The CACA Guidelines will also be published as a guide for the treatment of malignant tumors in China. technical means guide composition.
CACA Guidelines for Liver Cancer Tablet:
Liver cancer is the 5th most common malignant tumor and the 2nd leading cause of tumor death in China, posing a serious threat to the lives and health of our people. Existing international diagnostic and treatment guidelines are unable to take into account the disease background of liver cancer in China, regional differences in diagnostic and treatment resources, and the social value of tumor treatment in clinical practice, making it difficult to achieve individualized diagnostic and treatment decisions.
The Liver Cancer Committee of the Chinese Anti-Cancer Association (CACA) has organized experts in the field to formulate the "Chinese Guidelines on Integrated Diagnosis and Treatment of Liver Cancer" based on the method of evidence-based medicine, which covers the epidemiology of liver cancer, screening, imaging, pathology evaluation, surgical treatment, interventional therapy, systemic drug therapy, multidisciplinary and integrated therapeutic means such as radiotherapy and traditional Chinese medicine, and the whole process of rehabilitation management, and so on.
Hepatocellular carcinoma is a multifactorial and synergistic process of initiation, cancer promotion and evolution, and is the result of multiple gene mutations. According to the available information, hepatitis viruses, aflatoxins, drinking water contamination and non-alcoholic fatty liver disease are the major factors associated with the development of liver cancer.